Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Autoinducer-2-binding periplasmic protein LsrB (LsrB) is a critical component of the quorum-sensing apparatus in various Gram-negative bacteria, including Escherichia coli and Salmonella enterica (UniProt P0AEU3). It functions as the primary periplasmic receptor for autoinducer-2 (AI-2), a signaling molecule often termed the universal language for interspecies bacterial communication (Xavier & Bassler, 2005). LsrB specifically binds the (2R,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran (R-THMF) form of AI-2 and facilitates its transport into the cytoplasm via the Lsr ABC transporter system (Miller et al., 2004). Once internalized, AI-2 is processed to regulate gene expression related to biofilm formation, virulence, and metabolic adaptation, making LsrB a focal point for bacterial group behavior (Ha et al., 2013). As a therapeutic target, LsrB is being explored for the development of anti-virulence agents that aim to disrupt bacterial coordination without killing the cells, thereby minimizing the selective pressure for antibiotic resistance (Galloway et al., 2011). Research into LsrB inhibitors, such as AI-2 analogs and small-molecule antagonists, seeks to deafen pathogens and attenuate their ability to cause disease (Ryu et al., 2016).
Competitive inhibition of autoinducer-2 (AI-2) binding to the periplasmic receptor, preventing the internalization of the signaling molecule and subsequent activation of quorum sensing-regulated virulence genes (Ryu et al., 2016).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Autoinducer-2-binding periplasmic protein LsrB (LsrB) (LsrB).